Application scenario of extracorporeal carbon dioxide removal technology in Intensive Care Unit

doi:10.3877/cma.j.issn.2096-1537.2023.01.008

Abstract

Abstract:

Extracorporeal carbon dioxide removal (ECCO₂R) is an extracorporeal life support technology, designed to remove excessive carbon dioxide generated by the body through extracorporeal membrane lung ("artificial lung"), thus reducing patients' ventilatory demand and ventilator support level. With the improvement of related extracorporeal life support technologies and the accumulation of clinical experience, recent studies have suggested that ECCO₂R has important potential value in a variety of clinical scenarios. However, it is still imperative but it is urgent to further standardize its clinical indications and bedside management through large sample clinical studies. This article reviewed the application value of ECCO₂R in severe application scenarios, such as acute respiratory distress syndrome (ARDS), acute exacerbation of chronic obstructive pulmonary disease (AECOPD), perioperative period of lung transplantation, and persistent status of asthma, so as to provide more reference for the application of ECCO₂R in severe clinical scenarios.

Key words: Extracorporeal carbon dioxide removal, Acute respiratory distress syndrome, Acute exacerbation of chronic obstructive pulmonary disease, Perioperative period of lung transplantation, Persistent status of asthma

Jingen Xia, Shiyu Hu. Application scenario of extracorporeal carbon dioxide removal technology in Intensive Care Unit[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2023, 09(01): 40-45.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://icu.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2096-1537.2023.01.008

https://icu.cma-cmc.com.cn/EN/Y2023/V09/I01/40

Figures/Tables 1

References 48

1	Gattinoni L, Agostoni A, Pesenti A, et al. Treatment of acute respiratory failure with low-frequency positive-pressure ventilation and extracorporeal removal of CO₂ [J]. Lancet, 1980, 2(8189): 292-294.
2	Morris AH, Wallace CJ, Menlove RL, et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO₂ removal for adult respiratory distress syndrome [J]. Am J Respir Crit Care Med, 1994, 149(2 Pt 1): 295-305.
3	Combes A, Auzinger G, Capellier G, et al. ECCO₂R therapy in the ICU: consensus of a European round table meeting [J]. Crit Care, 2020, 24(1): 490.
4	Boyle AJ, Sklar MC, McNamee JJ, et al. Extracorporeal carbon dioxide removal for lowering the risk of mechanical ventilation: research questions and clinical potential for the future [J]. Lancet Respir Med, 2018, 6(11): 874-884.
5	Cove ME, MacLaren G, Federspiel WJ, et al. Bench to bedside review: Extracorporeal carbon dioxide removal, past present and future [J]. Crit Care, 2012, 16(5): 232.
6	Staudinger T. Update on extracorporeal carbon dioxide removal: a comprehensive review on principles, indications, efficiency, and complications [J]. Perfusion, 2020, 35(6): 492-508.
7	Combes A, Brodie D, Aissaoui N, et al. Extracorporeal carbon dioxide removal for acute respiratory failure: a review of potential indications, clinical practice and open research questions [J]. Intensive Care Med, 2022, 48(10): 1308-1321.
8	Karagiannidis C, Philipp A, Strassmann S, et al. Extracorporeal CO₂ Elimination (ECCO₂R) for Hypercapnic Respiratory Failure: From Pathophysiology to Clinical Application [J]. Pneumologie, 2017, 71(4): 215-220.
9	Schmidt M, Tachon G, Devilliers C, et al. Blood oxygenation and decarboxylation determinants during venovenous ECMO for respiratory failure in adults [J]. Intensive Care Med, 2013, 39(5): 838-846.
10	中华医学会呼吸病学分会呼吸危重症医学学组. 急性呼吸窘迫综合征患者机械通气指南 (试行) [J]. 中华医学杂志, 2016, 96(6): 404-424.
11	Gorman EA, O'Kane CM, McAuley DF. Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management [J]. Lancet, 2022, 400(10358): 1157-1170.
12	Terragni PP, Rosboch G, Tealdi A, et al. Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome [J]. Am J Respir Crit Care Med, 2007, 175(2): 160-166.
13	Hager DN, Krishnan JA, Hayden DL, et al. Tidal volume reduction in patients with acute lung injury when plateau pressures are not high [J]. Am J Respir Crit Care Med, 2005, 172(10): 1241-1245.
14	Rozencwajg S, Guihot A, Franchineau G, et al. Ultra-protective ventilation reduces biotrauma in patients on venovenous extracorporeal membrane oxygenation for severe acute respiratory distress syndrome [J]. Crit Care Med, 2019, 47(11): 1505-1512.
15	Schmidt M, Pham T, Arcadipane A, et al. Mechanical ventilation management during extracorporeal membrane oxygenation for acute respiratory distress syndrome. an international multicenter prospective cohort [J]. Am J Respir Crit Care Med, 2019, 200(8): 1002-1012.
16	Terragni PP, Del SL, Mascia L, et al. Tidal volume lower than 6 ml/kg enhances lung protection: role of extracorporeal carbon dioxide removal [J]. Anesthesiology, 2009, 111(4): 826-835.
17	Bein T, Weber-Carstens S, Goldmann A, et al. Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO₂ removal versus 'conventional' protective ventilation (6 ml/kg) in severe ARDS: the prospective randomized Xtravent-study [J]. Intensive Care Med, 2013, 39(5): 847-856.
18	Combes A, Fanelli V, Pham T, et al. Feasibility and safety of extracorporeal CO₂ removal to enhance protective ventilation in acute respiratory distress syndrome: the SUPERNOVA study [J]. Intensive Care Med, 2019, 45(5): 592-600.
19	McNamee JJ, Gillies MA, Barrett NA, et al. Effect of lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal vs standard care ventilation on 90-day mortality in patients with acute hypoxemic respiratory failure: the REST randomized clinical trial [J]. JAMA, 2021, 326(11): 1013-1023.
20	Boyle AJ, McDowell C, Agus A, et al. Acute hypoxaemic respiratory failure after treatment with lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal: long-term outcomes from the REST randomised trial [J]. Thorax, 2022, 5: thoraxjnl-2022-218874.
21	Abrams D, Schmidt M, Pham T, et al. Mechanical ventilation for acute respiratory distress syndrome during extracorporeal life support. Research and practice [J]. Am J Respir Crit Care Med, 2020, 201(5): 514-525.
22	Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019 [J]. Lancet, 2020, 396(10258): 1204-1222.
23	Organization WH. The top 10 causes of death [EB/OL]. (2020-09) [2022-09]. URL
24	中华医学会重症医学分会. 慢性阻塞性肺疾病急性加重患者的机械通气指南(2007) [J]. 中国危重病急救医学, 2007, 19(9): 513-518.
25	Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure [J]. Eur Respir J, 2017, 50(2): 1602426.
26	Patil SP, Krishnan JA, Lechtzin N, et al. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease [J]. Arch Intern Med, 2003, 163(10): 1180-1186.
27	Demoule A, Girou E, Richard JC, et al. Benefits and risks of success or failure of noninvasive ventilation [J]. Intensive Care Med, 2006, 32(11): 1756-1765.
28	D'Andrea A, Banfi C, Bendjelid K, et al. Utilisation de l'épuration extra-corporelle de dioxyde de carbone dans l'exacerbation de la maladie pulmonaire obstructive chronique: une revue narrative [J]. Can J Anaesth, 2020, 67(4): 462-474.
29	Combes A, Brodie D, Aissaoui N, et al. Extracorporeal carbon dioxide removal for acute respiratory failure: a review of potential indications, clinical practice and open research questions [J]. Intensive Care Med, 2022, 48(10): 1308-1321.
30	Boyle AJ, Sklar MC, McNamee JJ, et al. Extracorporeal carbon dioxide removal for lowering the risk of mechanical ventilation: research questions and clinical potential for the future [J]. Lancet Respir Med, 2018, 6(11): 874-884.
31	Morales-Quinteros L, Del SL, Artigas A. Extracorporeal carbon dioxide removal for acute hypercapnic respiratory failure [J]. Ann Intensive Care, 2019, 9(1): 79.
32	Kluge S, Braune SA, Engel M, et al. Avoiding invasive mechanical ventilation by extracorporeal carbon dioxide removal in patients failing noninvasive ventilation [J]. Intensive Care Med, 2012, 38(10): 1632-1639.
33	Del SL, Pisani L, Filippini C, et al. Extracorporeal CO₂ removal in hypercapnic patients at risk of noninvasive ventilation failure: a matched cohort study with historical control [J]. Crit Care Med, 2015, 43(1): 120-127.
34	Braune S, Sieweke A, Brettner F, et al. The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case-control study [J]. Intensive Care Med, 2016, 42(9): 1437-1444.
35	Cardenas VJ, Lynch JE, Ates R, et al. Venovenous carbon dioxide removal in chronic obstructive pulmonary disease: experience in one patient [J]. ASAIO J, 2009, 55(4): 420-422.
36	Abrams DC, Brenner K, Burkart KM, et al. Pilot study of extracorporeal carbon dioxide removal to facilitate extubation and ambulation in exacerbations of chronic obstructive pulmonary disease [J]. Ann Am Thorac Soc, 2013, 10(4): 307-314.
37	Burki NK, Mani RK, Herth F, et al. A novel extracorporeal CO₂ removal system: results of a pilot study of hypercapnic respiratory failure in patients with COPD [J]. Chest, 2013, 143(3): 678-686.
38	Pisani L, Polastri M, Pacilli A, et al. Extracorporeal Lung Support for Hypercapnic Ventilatory Failure [J]. Respir Care, 2018, 63(9): 1174-1179.
39	Bartosik W, Egan JJ, Wood AE. The Novalung interventional lung assist as bridge to lung transplantation for self-ventilating patients - initial experience [J]. Interact Cardiovasc Thorac Surg, 2011, 13(2): 198-200.
40	Ricci D, Boffini M, Del SL, et al. The use of CO₂ removal devices in patients awaiting lung transplantation: an initial experience [J]. Transplant Proc, 2010, 42(4): 1255-1258.
41	Schellongowski P, Riss K, Staudinger T, et al. Extracorporeal CO₂ removal as bridge to lung transplantation in life-threatening hypercapnia [J]. Transpl Int, 2015, 28(3): 297-304.
42	Mascia L, Pasero D, Slutsky AS, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial [J]. JAMA, 2010, 304(23): 2620-2627.
43	Lucangelo U, Del SL, Boffini M, et al. Protective ventilation for lung transplantation [J]. Curr Opin Anaesthesiol, 2012, 25(2): 170-174.
44	Christie JD, Sager JS, Kimmel SE, et al. Impact of primary graft failure on outcomes following lung transplantation [J]. Chest, 2005, 127(1): 161-165.
45	Ruberto F, Bergantino B, Testa M C, et al. Low-flow venovenous CO₂ removal in association with lung protective ventilation strategy in patients who develop severe progressive respiratory acidosis after lung transplantation [J]. Transplant Proc, 2013, 45(7): 2741-2745.
46	Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention [EB/OL]. (2022-07-01) [2022-11-22]. URL
47	Laher AE, Buchanan SK. Mechanically Ventilating the Severe Asthmatic [J]. J Intensive Care Med, 2018, 33(9): 491-501.
48	Bromberger BJ, Agerstrand C, Abrams D, et al. Extracorporeal Carbon Dioxide Removal in the Treatment of Status Asthmaticus [J]. Crit Care Med, 2020, 48(12): e1226-e1231.

[1]	Lung Transplantation Study Group, Branch of Organ Transplantation of Chinese Medical Association;, National Lung Transplantation Quality Control Center. Selection of lung transplant candidates with COVID-19: Advises from China lung transplant expert group [J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(01): 13-16.
[2]	Ting Luo, Shi Zhang. Prognostic analysis of 5 biomarkers for acute respiratory distress syndrome [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2023, 16(04): 471-475.
[3]	Yue Liao, Ke Wang, Jiangyue Qin, Yanqiu Wu, Jun Chen, Tao Wang, Fuqiang Wen, Hao Wang. Efficacy of Danlong oral liquid in treatment of mild-to-moderate acute exacerbation of chronic obstructive pulmonary disease: A multicenter, prospective, observational cohort study [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2023, 16(03): 306-311.
[4]	Zongjun Hu, Xi Yue, Xia Huang. Effect of bronchopulmonary segments recruitment on the survival of patients with severe acute respiratory distress syndrome [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2022, 15(06): 796-800.
[5]	Sha Tao, Jing Lu, Yue Shen, Wei Zheng Shuai, Zhenhua Wang. Clinical observation of prone position mechanical ventilation in AECOPD patients [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2022, 15(06): 792-795.
[6]	Rui Chen, Hongna Yang, Wei Fang, Xinxin Li, Tiantian Li, Xiaoyi Yu, Yanxue Wang, Wenyu Li. Correlation between the cytokine levels in serum and BALF and intrapulmonary and extrapulmonary ARDS [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2023, 09(03): 251-258.
[7]	Meiqing Wu, Jin Lin, Meili Duan, Xiaoyan Xue. Effect of high density lipoprotein level on the occurrence of sepsis-related acute respiratory distress syndrome [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2023, 09(02): 191-197.
[8]	Chengfen Yin, Lei Xu. Talk about the timing of prone position ventilation again [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2023, 09(01): 9-13.
[9]	Dongyu Chen, Chun Pan, Yi Yang. Techniques to monitor respiratory effort in acute respiratory distress syndrome [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2023, 09(01): 84-88.
[10]	Jieqiong Wang, Huixia Wang, Huiying Zhao, Youzhong An. Regulation of angiotensin converting enzyme 2 on inflammatory injury of human pulmonary microvascular endothelial cells [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2023, 09(01): 78-83.
[11]	Yumei Wang, Yan Wang, Yimin Zhou, Mingyue Miao, Yanlin Yang, Linlin Zhang, Ming Xu, Jianxin Zhou. Application of regional recruitment-to-inflation ratio monitored by electrical impedance tomography in the models of acute respiratory distress syndrome [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2022, 08(04): 360-366.
[12]	Chengfen Yin, Lei Xu. Settings of mechanical ventilation during V-V ECMO support in ARDS patients [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2022, 08(04): 378-383.
[13]	Yonghai Liu, Hang Qi, Ting Zhou, Wei Zhang. A case of community-acquired Acinetobacter baumannii pneumonia and a literature review [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2022, 08(03): 276-280.
[14]	Qing Ma, Yang Yao, Yimeng Peng, Siyu Li, Ge Ding, Shengyu. Wang. Application of SpO₂/FiO₂ in predicting the clinical outcome of patients with ARDS [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2022, 08(02): 140-146.
[15]	Kunyang Li, Li Zhang. Risk factors for acute exacerbation of chronic obstructive pulmonary disease complicated with diabetes [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(06): 493-500.

Please choose a citation manager

Content to export